Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder
Conclusion. The audio-digital recording method provides a useful second opinion that can affirm the need for a different treatment intervention in these anxious patients. A second live assessment would have required additional clinic time and added patient burden. The audio-digital recording method is less burdensome than live second opinion assessments and might have utility in both research and clinical practice settings. Keywords: Generalized anxiety disorder (GAD), anxiolytic medications, anxious symptoms, audio-digital recording, dual review, second opinions Anxiety symptoms are prevalent in most populations where people experience the stress of modern life. A cluster of anxiety symptoms becomes an anxiety disorder when the symptoms are difficult to control, cause significant distress for the person, and impact the ability to function.1,2 It has been reported that patients who meet diagnostic criteria for generalized anxiety disorder (GAD) might also have substantial economic and social burden as a consequence of the disorder.3–7 There are several effective treatments for GAD, including psychotropic medications, complementary and alternative medicines, psychotherapy, cognitive-behavioral therapy, and/or other nonpharmacological strategies that can be given to address troubling and/or disruptive anxiety symptoms.6–10 The use of psychotropic medications for treating anxiety symptoms, including approved antidepressants, is sometimes challenged because other...
Authors: Siamashvili M, Davis S Abstract INTRODUCTION: Bromocriptine mesylate quick release (QR) is a dopamine D2 receptor agonist and is the only oral, primarily centrally acting drug that can be used for the treatment of adults with type 2 diabetes. AREAS COVERED: The authors describe current recommendations on the use of bromocriptine mesylate QR. Major efficacy and safety parameters of the late phase trials, including The Cycloset Safety Trial, have been identified and presented. EXPERT OPINION: Efficacy of bromocriptine mesylate QR monotherapy appears to be low but is compensated by favorable safety pr...
Abstract Trace metals concentrations of 25 elements were determined for 22 subcomponents of biodegradable and non-biodegradable waste samples representing the United States municipal solid waste (MSW) stream collected during three separate waste sorts. The subcomponent trace metal concentrations and estimated composition results were used to predict trace metal concentrations present in the overall MSW stream along with MSW compost and waste to energy (WTE) ash, which were compared to health-based standards (i.e., US EPA regional screening levels) and to values previously reported in the literature. These estimate...
Acceptance of trauma can also help to reduce its damaging effects. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Publication date: Available online 9 October 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Vanda Craveiro, Elisabete Ramos, Joana Araújo
The behavior is linked to more white matter, the brain's 'superhighway'. → Support PsyBlog for just $5 per month. Enables access to articles marked (M) and removes ads. → Explore PsyBlog's ebooks, all written by Dr Jeremy Dean: Accept Yourself: How to feel a profound sense of warmth and self-compassion The Anxiety Plan: 42 Strategies For Worry, Phobias, OCD and Panic Spark: 17 Steps That Will Boost Your Motivation For Anything Activate: How To Find Joy Again By Changing What You Do
Publication date: Available online 10 October 2020Source: Brain, Behavior, and ImmunityAuthor(s): Irene Esteban-Cornejo, Chelsea M. Stillman, Maria Rodriguez-Ayllon, Arthur F. Kramer, Charles H. Hillman, Andrés Catena, Kirk I. Erickson, Francisco B. Ortega
Publication date: October 2020Source: Brain, Behavior, and Immunity, Volume 89Author(s): Mario Gennaro Mazza, Rebecca De Lorenzo, Caterina Conte, Sara Poletti, Benedetta Vai, Irene Bollettini, Elisa Maria Teresa Melloni, Roberto Furlan, Fabio Ciceri, Patrizia Rovere-Querini, COVID-19 BioB Outpatient Clinic Study group, Francesco Benedetti
Publication date: October 2020Source: Brain, Behavior, and Immunity, Volume 89Author(s): Xiaoqin Liu, Trine Munk-Olsen, Clara Albiñana, Bjarni J. Vilhjálmsson, Emil M. Pedersen, Vivi Schlünssen, Marie Bækvad-Hansen, Jonas Bybjerg-Grauholm, Merete Nordentoft, Anders D. Børglum, Thomas Werge, David M. Hougaard, Preben B. Mortensen, Esben Agerbo
Publication date: October 2020Source: Brain, Behavior, and Immunity, Volume 89Author(s): Fernando Lopes, Fernando A. Vicentini, Nina L. Cluny, Alexander J. Mathews, Benjamin H. Lee, Wagdi A. Almishri, Lateece Griffin, William Gonçalves, Vanessa Pinho, Derek M. McKay, Simon A. Hirota, Mark G. Swain, Quentin J. Pittman, Keith A. Sharkey
More News: Agoraphobia | Alprazolam | Anxiety | Binge Eating Disorder | Biotechnology | Bipolar | Brain | Buspirone | Celexa | Citalopram | Clinical Trials | Clonazepam | Cymbalta | Depression | Eating Disorders & Weight Management | Education | Effexor | Epidemics | Epidemiology | Gabapentin | Generalized Anxiety Disorder (GAD) | Grants | Health Management | Hyperthyroidism | International Medicine & Public Health | Klonopin | Legislation | Lexapro | Mania | Medical Ethics | Men | Neurology | Neurontin | Obesity | Obsessive Compulsive Disorder | Occupational Health | Panic Disorder | Paroxetine | Paxil | Pfizer | Phobias | Post Traumatic Stress Disorder | Psychiatry | Psychotherapy | Sertraline | Sleep Disorders | Sleep Medicine | Social Anxiety Disorder | Statistics | Study | Substance Abuse | Substance Abuse Disorders | Training | UK Health | Universities & Medical Training | USA Health | WHO | Women | Xanax | Zoloft